Moleculight i:X™ in Wound Healing

Status Recruiting

Clinical Trial Summary

Diabetic foot disease is a global health problem. Diabetes affects over 450million people worldwide, expected to rise to 1 in 10 people by 2040. 60-70% will lose sensation in their feet and up to 25% will develop a diabetic foot ulcer (DFU - a wound on the foot). More than half of DFUs become infected requiring hospitalisation and 20% of infections result in amputations contributing to 80% of non-traumatic amputations performed in the developed world. DFUs cost the NHS £1billion in financial year 2014-15.

A diabetic foot ulcer is a form of chronic wound. Chronic wounds are wounds that fail to progress through the normal phases of wound healing in an orderly and timely manner and become hard to heal. Almost all chronic wounds are known to have bacteria within and this is termed colonisation. Wounds can progress from being colonised to becoming infected. The concentration of bacteria can predict delayed healing or infection.

This study aims to use a novel hand held device, Moleculight i:X™, in a pilot study to investigate the clinical effectiveness and decision making associated with its use in the assessment of DFUs. Moleculight i:X™ is a hand held device that emits violet blue light. By controlling distance from the wound and ambient light, Moleculight i:X™ identifies bacteria above a pre-determined concentration by identifying natural fluorescence in the bacteria cell wall.

Patients attending a specialist DFU clinic will be screened and if eligible and consenting will be recruited. Patients will be randomised into two groups; those who receive treatments as usual (TAU) alone (in line with NICE guidelines) and those that receive TAU plus Moleculight i:X™ imaging. The main objective is to describe the proportion per group with healed DFUs at 12week follow up in these two comparable groups of 30 patients each.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Ulcer Foot

Clinical Trial Details

NCT number	NCT03270904
Study type	Interventional
Source	The Leeds Teaching Hospitals NHS Trust
Contact	David Russell, MB ChB, MD
Phone	+44 113 243 2799
Email	davidrussell1@nhs.net
Status	Recruiting
Phase	N/A
Start date	December 1, 2017
Completion date	August 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03675269` - Adjunctive Hyperbaric Oxygen Therapy (HBOT) for Lower Extermity Diabetic Ulcer:	N/A
Terminated	`NCT05234632` - Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds	N/A
Not yet recruiting	`NCT04537676` - Patient Empowerment Study
Completed	`NCT05101473` - Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study	N/A
Recruiting	`NCT04210089` - Total Contact Soft Cast in Diabetic Foot Ulcers	N/A
Completed	`NCT03985306` - Treatment of Diabetic Foot Ulcers With Inforatio Technique to Promote Wound Healing	N/A
Completed	`NCT05564728` - Diabetes Footcare Companion App for Patients and Carers
Not yet recruiting	`NCT06449638` - Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs	N/A
Completed	`NCT04065594` - Platelet Rich Plasma (PRP) Bio Stimulant Gel Dressing in Treating Chronic Non Healing Leg and Foot Ulcers: Cost and Effectiveness	N/A
Completed	`NCT03883230` - Wound Infection Detection Evaluation, WIDE
Completed	`NCT05883098` - SDRM® vs. Collagen for Diabetic Foot Ulcers	N/A
Completed	`NCT02986256` - Evaluation of the Management of Diabetic Foot Ulcers by Telemedicine on the Number of Hospital Days in Diabetic Patients	N/A
Terminated	`NCT03479242` - Diabetic Foot Ulcer Recurrence: Pilot Study
Recruiting	`NCT06124586` - Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)	N/A
Not yet recruiting	`NCT05251480` - Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People	N/A
Completed	`NCT03398538` - Resorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers	N/A
Terminated	`NCT04123093` - Safety and Efficacy of the Noxsano Wound Care Bandage	N/A
Completed	`NCT04040426` - Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers	N/A
Recruiting	`NCT06403605` - Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers	N/A
Completed	`NCT03881254` - SkinTE™ in the Treatment of Diabetic Foot Wounds	N/A